Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|December 3, 2025
Rethinking the seven-day treatment-free interval in T-cell engager therapy using agent-based modelingNina Obertopp, Matthew Froid, Shari Pilon-Thomas, et al.Radiation Oncology (London, England)|September 13, 2024
Spatially fractionated GRID radiation potentiates immune-mediated tumor controlRebecca A Bekker, Nina Obertopp, Gage Redler, et al.Cellular Immunology|January 21, 2021
Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapyPatrick Innamarato, Shari Pilon-ThomasMolecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2025
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo A Nicolaci, Kim C Tran, et al.Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo Nicolaci, Kim C Tran, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 9, 2008
Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanomaNobusada Koike, Shari Pilon-Thomas, James J MuléInternational Journal of Radiation Oncology, Biology, Physics|June 29, 2025
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating LymphocytesNina Obertopp, Rebecca A Bekker, G Daniel Grass, et al.Neoplasia (New York, N.Y.)|April 21, 2022
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune systemRebecca Anne Bekker, Sungjune Kim, Shari Pilon-Thomas, et al.Frontiers in Immunology|June 15, 2026
Artificial intelligence for optimization of immunotherapy: current applications and transformative potentialAli Tarhini, Palak Dave, Shari Pilon-Thomas, et al.Pageof 16